Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System

NCT: NCT05540223 · ACTIVE_NOT_RECRUITING

NCT IDNCT05540223
StatusACTIVE_NOT_RECRUITING
Start Date2024-05-13
SponsorBiotronik AG (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to assess the safety and efficacy of the Freesolve in the treatment of subjects with up to two de novo lesions in native coronary arteries compared to a contemporary drug eluting stent (DES).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑